Pharmaceutical manufacturing and clinical research operations in Poland
Servier Polska operates a manufacturing and clinical research facility for the Paris-based Servier group, running production at the Anpharm plant in Warsaw and managing clinical trials through an international research center. The tech stack is heavily weighted toward manufacturing execution (SAP S/4HANA, MES, Maximo, AutoCAD, Siemens PLC, HPLC) and supply-chain planning (Kinaxis RapidResponse), reflecting a factory-first operational model. Active hiring is concentrated in manufacturing and ops roles with a mid-to-senior profile, aligned to concurrent projects in tech transfer, new production buildings, and production digitalization—signaling ongoing capital investment and process modernization.
Notable leadership hires: MSAT Lead
Servier Polska is the Polish subsidiary of the France-headquartered Servier pharmaceutical group, operating since 1992 with local manufacturing since 1997. The Warsaw facility (Anpharm) produces nearly all Servier drug packages for Poland and exports approximately half of output across the EU. The site also hosts an International Clinical Research Center responsible for running and coordinating clinical trials. The organization spans manufacturing, quality assurance, logistics, and engineering functions across 501–1,000 employees, with primary focus on GMP-compliant production, supply-chain stability, and supporting the group's cardiology, oncology, and neurology pipelines.
SAP S/4HANA for ERP, MES for production execution, Maximo for maintenance management, Siemens S7-300 PLCs for automation, Allen-Bradley Studio 5000 for control logic, HPLC for analytical testing, and Kinaxis RapidResponse for supply planning.
The Warsaw Anpharm facility produces nearly 100% of Servier drug packages for Poland, with ~50% of output exported mainly to EU countries. Active ingredients (APIs) are sourced from within the EU.
Other companies in the same industry, closest in size